Eli Lilly and Co said its type 2 diabetes drug was more effective than Sanofi SA’s approved drug Lantus in reducing patients’ blood sugar levels in three late-stage trials.
Read more
Reuters – Lilly’s diabetes drug better than Sanofi’s in late-stage trials
Posted in Drugs